 |
| MAY
15, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- BrainChild Bio: FDA Grants Regenerative
Medicine Advanced Therapy Designation for
B7-H3 CAR T-cell Therapy for Incurable
Pediatric Brain Tumors More
- Dyno Therapeutics: Inaugural 2025 Genetic
Agency Technology Conference and Launch of
Dyno Frontiers Program to Accelerate Progress
in Patient-Empowering Gene Therapies More
- Dyno Therapeutics: Launches Three
Breakthrough Capsid Delivery Vectors for
Next-Generation Eye, Muscle and CNS Gene
Therapies at the 2025 American Society of Gene
& Cell Therapy (ASGCT) Annual Meeting More
- Excision BioTherapeutics: Presents Data From
HBV and HSV Programs at the ASGCT 2025 Annual
Meeting More
- Mansfield Bio-Incubator: Reveals Contestants
and Judging Panel for $80K Pitch Competition
on June 12, 2025 More
- QurAlis: Exclusive License on Novel
Mechanism for Fragile X Syndrome (FXS) to
Enable Development of First Potential
Disease-Modifying Therapy More
- Sarepta Therapeutics: Approval in Japan of
ELEVIDYS, a Gene Therapy to Treat Duchenne
Muscular Dystrophy More
- Sensory Cloud: REACH Trial Evaluating
First-Line Treatment of Refractory Chronic
Cough Completes Enrollment More
- Takeda: The New England Journal of Medicine
Publishes Data From Phase 2b Trial of Oral
Orexin Receptor 2 Agonist Oveporexton
(TAK-861) in People With Narcolepsy Type 1 More
- Viralgen: Joins Orphan Therapeutics
Accelerator Clinical Development Network as a
Manufacturing Partner to Advance Rare Disease
Therapies More
- Voyager: Demonstrates ALPL Receptor-Mediated
Blood-Brain Barrier Transport of Novel AAV
Capsids in Molecular Therapy Publication More
|
|
 |
Strategic
CFO Services for Scaling Biotech
Startups
Explore how biotech startups can
leverage fractional CFO services
to scale efficiently |
|
Learn More
→ |
|
|
|
- Akari Therapeutics: First Quarter 2025
Financial Results and Provides Corporate
Update More
- Apellis’ Weak Quarter for Syfovre Signals
Uphill Climb for Geographic Atrophy Med:
Analyst More
- Aura Biosciences: First Quarter 2025
Financial Results and Business Highlights More
- Aura Biosciences: Proposed Public Offering
of Common Stock and Warrants More
- bluebird bio: Carlyle, SK Capital
Partners and bluebird bio Amend Merger
Agreement More
More
More
- Elevation Oncology: First Quarter 2025
Financial Results and Provides Business
Updates More
- Enveric Biosciences: First Quarter 2025
Financial and Corporate Results More
- Inhibikase Therapeutics: First Quarter 2025
Financial Results and Highlights Recent
Activity More
- Invivyd: First Quarter 2025 Financial
Results and Recent Business Highlights More
- Mersana Therapeutics: Business Update and
Announces First Quarter 2025 Financial Results
More
- MetaVia: First Quarter 2025 Financial
Results and Provides Corporate Update More
- More on GSK Paying Up to $2B for Rights to
Boston Firm’s Liver Disease Drug More*
More
- More on Leap Halving Head Count,
Narrowing Lead Cancer Drug’s Focus Amid
‘Difficult Market Environment’ More
More*
- Pyxis Oncology: First Quarter 2025 Financial
Results and Provides Business Update More
- scPharmaceuticals: First Quarter 2025
Financial Results and Provides Business Update
More
- Stylus Medicine: Launches to Develop
Precision, In Vivo Genetic Medicines and
Unlock the Full Potential of CAR-T Therapy More
More
More
More*
- Top 10 Best-Selling Gene Therapies More
- Trump Administration Axes $450M More in
Grant Funding to Harvard More
More*
- Verastem Oncology: First Quarter 2025
Financial Results and Highlights Recent
Business Updates More
- Zenas BioPharma: First Quarter 2025
Financial Results and Provides Corporate
Updates More
|
|
|
|
- Broad: #WhyIScience Q&A - A Systems
Biologist Uses AI to Understand How the Genome
Controls Cell Fate More
- Empty Lab Space in Greater Boston Keeps
Piling Up More*
- LabCentral: Designing and Engineering
Scalable Cell and Gene Therapies More
- Leveraging Synergies: How a Merger
Provides Speed, Flexibility, and a Unified
Offering for Customers Podcast
- Mass. Biotech Leaders Say Drug-Pricing Order
‘Not the Solution’ More*
More*
- More on Ring Therapeutics Presenting
Promising New Data on Its AnelloBricks
Biomanufacturing Platform at ASCGT More
- Petri Dish: bluebird Buyers Sweeten Deal;
RA, Khosla Launch Biotech More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
- Test-Time Scaling Improves Speed and Success
of AI-Based Antibody Design More
- The Top Line: Angela Hwang on Her Pivot From
Big Pharma to Biotech Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
highlighted on our
website. |
|
|
|
|
|
|
NOTE: EVENTS AND JOBS ARE FROM
ALL BIG4BIO REGIONS
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- OPPORTUNITY: Chief Executive Officer More
- OPPORTUNITY: Chief Product Officer More
- OPPORTUNITY: Vice President, Digital Health
Business Development More
- OPPORTUNITY: Chief Business Officer More
- OPPORTUNITY: Vice President, Finance More
- OPPORTUNITY: Director, Compliance &
Quality Systems More
- OPPORTUNITY: West Coast Business Development
Director More
- OPPORTUNITY: Chief Financial Officer More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
